Osteoporosis is often called a silent disease because it goes undiagnosed until a fracture occurs. In this workshop recording, Medimaps' clinical leadership team walks through how the TBS® ecosystem is designed to close that gap at every stage of the patient journey — not just at the point of diagnosis, but opportunistically, wherever a scan is already being taken.
The session covers the next generation of TBS Osteo™, including expanded patient eligibility and centralized management across multiple DXA systems, before introducing TBS Reveal™, Medimaps' opportunistic screening approach for identifying bone-fragility risk from routine X-rays.
Together, the two represent a single, connected approach to bone health: Identify risk earlier, refer appropriately, and support treatment decisions with both bone density and bone microarchitecture.
About this video
What you'll learn
Topics covered include the next-generation capabilities of TBS Osteo™, how the Medimaps ecosystem integrates into existing radiology workflows, and an introduction to the opportunistic screening approach of TBS Reveal™
Featuring
Prof. Didier Hans
CEO & Co-founder, Medimaps
Prof. Karen Hind
VP of Clinical Affairs, Research & Innovation, Medimaps
